Search
for

    Learn

    5 / 801 results

      learn Finasteride

      Frontline, gold standard treatment for combatting androgenic alopecia

      learn Adenosine

      nucleoside used for hair regrowth stimulant properties

      learn Alfatradiol

      a synthetic estrogen used topically as an anti-androgen

      learn Dutasteride

      Heavy duty finasteride that comes with higher risks, but scalp injections seem safe and are gaining popularity

    Research

    5 / 1000+ results

    Community Join

    5 / 105 results

      community New potential hair loss treatment (news release)

      in Treatment  186 upvotes 5 years ago
      New potential hair loss treatment uses molecules from hairy moles to stimulate follicle growth. Topical solution requires less frequent application, like Botox injections a few times per year.

      community KX-826: Long-Term Safety Results are out!

      in Research/Science  161 upvotes 1 year ago
      KX-826 initially improves hair growth but declines after 24 weeks, with mild itching as a side effect. Combining it with minoxidil and finasteride may improve results, but long-term effectiveness is uncertain.

      community M30, month 3 of dutasteride and minoxidil

      in Progress Pictures  312 upvotes 8 months ago
      A 30-year-old man shared his 3-month progress using dutasteride, minoxidil, ketoconazole shampoo, and tretinoin cream for hair loss, reporting no side effects. He also takes supplements like Vitamin D3, Calcium, Magnesium, and Zinc, and plans to add Biotin.

      community Pelage Announces Positive Results of Phase 2a Trials for PP405

      in Update  301 upvotes 9 months ago
      PP405 shows promise in treating severe hair loss, with 31% of users experiencing over 20% hair density increase in four weeks, faster than minoxidil and finasteride. Some users are skeptical about the results' significance and long-term efficacy.

      community Rejected for the 2nd time for the VDPHL01 Clinical Trials (believe it or not!)

      in Chat  12 upvotes 1 year ago
      The user was rejected from participating in a clinical trial for an extended-release oral Minoxidil due to having rheumatoid arthritis, despite initially being accepted. They had stopped using Dutasteride and Minoxidil to qualify but continued using other treatments like RU58841 and red light therapy.